# Differential Gene Expression in Differentiated Human Neuroblastoma SH-SY5Y Cells in Response to a Cocktail of Monoamine Oxidase Inhibitors

**Authors:** Prakshit Niraula, Rachel A. Page, Barry R. Palmer, Penelope Truman

PMC · DOI: 10.3390/ijms27041689 · 2026-02-09

## TL;DR

This study examines how a cocktail of monoamine oxidase inhibitors affects gene expression in neuroblastoma cells, finding that it alters genes linked to smoking-related diseases and addiction.

## Contribution

The study identifies specific genes altered by monoamine oxidase inhibitors, linking them to smoking-related conditions and addiction.

## Key findings

- MAOA and MAOB gene expression levels remained unchanged after exposure to treatments.
- Exposure to the MAOI cocktail altered 23 genes, with many linked to smoking-related diseases and addiction.
- Nicotine and tobacco smoke preparation each caused distinct gene expression changes.

## Abstract

Differentiated human neuroblastoma (SH-SY5Y) cells were exposed to either 0.2 μM nicotine, a tobacco smoke preparation (TPM) diluted to the same nicotine concentration, or a cocktail of seven tobacco smoke monoamine oxidase inhibitors (MAOIs) at the concentrations measured in the TPM. Treatment occurred for 3 days, such that the cellular monoamine oxidase (MAO) concentration was reduced by approximately 50% in both the TPM and MAOI cocktail exposure groups. Changes in MAO gene expression after exposure to the different treatments were determined using qPCR, and the effect of these exposure treatments on global gene expression was also examined using mRNA sequencing. No change in MAOA and MAOB gene expression levels was observed, after any treatment, either using qPCR or mRNA sequencing. The MAOI versus control treatment comparison revealed that four genes were >2-fold down-regulated (ZNF727, RP11-310E22.4, CRYM, SEMA3F), and 19 genes were up-regulated after 3 days’ exposure to the MAOI cocktail. Many of these differentially expressed genes were linked with disease conditions related to smoking and addiction. Exposure to nicotine and TPM each resulted in up- and down-regulation of different sets of genes. The results indicate that changes in MAO gene expression are unlikely to be responsible for the changes in MAO activity. The association between genes whose expression changes with tobacco MAO treatment and smoking-related diseases and addiction suggests the central role that MAO inhibition may play in mediating the effects of smoking on smokers.

## Linked entities

- **Genes:** MAOA (monoamine oxidase A) [NCBI Gene 4128], MAOB (monoamine oxidase B) [NCBI Gene 4129], ZNF727 (zinc finger protein 727) [NCBI Gene 442319], CRYM (crystallin mu) [NCBI Gene 1428], SEMA3F (semaphorin 3F) [NCBI Gene 6405]
- **Proteins:** mao (monoamine oxidase)
- **Chemicals:** nicotine (PubChem CID 942)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** DPP8 (dipeptidyl peptidase 8) [NCBI Gene 709428], SEMA3F (semaphorin 3F) [NCBI Gene 6405] {aka SEMA-IV, SEMA4, SEMAK}, MAOB (monoamine oxidase B) [NCBI Gene 4129], CRYM (crystallin mu) [NCBI Gene 1428] {aka DFNA40, THBP}, LINC00342 (long intergenic non-protein coding RNA 342) [NCBI Gene 150759] {aka NCRNA00342}, NOS1 [NCBI Gene 107819728], MAOA (monoamine oxidase A) [NCBI Gene 4128] {aka BRNRS, MAO-A}, ZNF727 (zinc finger protein 727) [NCBI Gene 442319] {aka ZNF727P}
- **Diseases:** Depression (MESH:D003866), breast, liver and lung cancer (MESH:D001943), degeneration of motor neurons (MESH:D009410), ALS (MESH:D000690), carcinogenic (MESH:D011230), toxicity (MESH:D064420), smoking (MESH:D015208), COPD (MESH:D029424), Neuroblastoma (MESH:D009447), inflammation (MESH:D007249), injury to (MESH:D014947), TPM (MESH:D014029), neurodegeneration (MESH:D019636), multiple diseases (MESH:D004194), Parkinson's Disease (MESH:D010300), pain (MESH:D010146), cancer (MESH:D009369), addiction (MESH:D019966), irritability (MESH:D001523), Alzheimer's (MESH:D000544), anxiety (MESH:D001007), schizophrenia (MESH:D012559), asthma (MESH:D001249)
- **Chemicals:** CO2 (MESH:D002245), catechols (MESH:D002396), 4-ethyl catechol (MESH:C527200), norharman (MESH:C010262), sucrose (MESH:D013395), lipids (MESH:D008055), DHA (MESH:D004281), 4-methyl catechol (MESH:C018599), TPM (MESH:D000077236), alcohol (MESH:D000438), morphine (MESH:D009020), dopamine (MESH:D004298), PBS (MESH:D007854), calcium (MESH:D002118), magnesium (MESH:D008274), serotonin (MESH:D012701), hexamethonium (MESH:D018738), S (MESH:D013455), heroin (MESH:D003932), tyramine (MESH:D014439), RPMI 1640 (-), Penicillin (MESH:D010406), PUFA (MESH:D005231), Retinoic acid (MESH:D014212), cocaine (MESH:D003042), fatty acid (MESH:D005227), L-arginine (MESH:D001120), Nicotine (MESH:D009538), amine (MESH:D000588), FAD (MESH:D005182), alpha-linolenic acid (MESH:D017962), water (MESH:D014867), catechol (MESH:C034221), norepinephrine (MESH:D009638), sarcosine (MESH:D012521), nitric oxide (MESH:D009569), harman (MESH:C005010), ethanol (MESH:D000431), linoleic acid (MESH:D019787), P (MESH:D010758), quinol (MESH:D006873), n-3 PUFA (MESH:D015525), Streptomycin (MESH:D013307), hydroquinone (MESH:C031927)
- **Species:** Macaca mulatta (rhesus macaque, species) [taxon 9544], Danio rerio (leopard danio, species) [taxon 7955], Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606], Nicotiana tabacum (American tobacco, species) [taxon 4097], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** SH-SY5Y — Homo sapiens (Human), Neuroblastoma, Cancer cell line (CVCL_0019), SH- SYY — Homo sapiens (Human), Neuroblastoma, Cancer cell line (CVCL_W974), 25 — Homo sapiens (Human), Gastric tubular adenocarcinoma, Cancer cell line (CVCL_W522), T — Homo sapiens (Human), Esophageal squamous cell carcinoma, Cancer cell line (CVCL_3174)

## Figures

13 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12940261/full.md

---
Source: https://tomesphere.com/paper/PMC12940261